Company Kodiak Sciences Inc.

Equities

KOD

US50015M1099

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
5.26 USD -29.40% Intraday chart for Kodiak Sciences Inc. -8.68% +73.03%

Business Summary

Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a technology platform for retinal medicines. The Company is engaged in preventing and treating the major causes of blindness by developing and commercializing next-generation therapeutics for chronic, high-prevalence retinal diseases. The Company's ABC Platform uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies. The Company's product candidate, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including diabetic eye diseases, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its KSI-501 is a dual inhibitor antibody biopolymer conjugate targeting both VEGF (VEGF-trap) and IL-6 (anti-IL-6 antibody) for the treatment of retinal diseases.

Number of employees: 116

Managers

Managers TitleAgeSince
Chief Executive Officer 51 08-12-31
Director of Finance/CFO 62 15-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 22-01-31
Corporate Officer/Principal - 17-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 55 15-08-31
Director/Board Member 70 19-12-16
Director/Board Member 66 18-07-17
Director/Board Member 74 18-05-31
Director/Board Member 53 18-07-17
Chief Executive Officer 51 08-12-31
Director/Board Member 65 20-04-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 52,472,291 49,500,304 ( 94.34 %) 0 94.34 %

Shareholders

NameEquities%Valuation
Baker Bros. Advisors LP
32.99 %
17,310,490 32.99 % 104 M $
BlackRock Advisors LLC
7.384 %
3,874,713 7.384 % 23 M $
2,695,038 5.136 % 16 M $
Acadian Asset Management LLC
3.637 %
1,908,302 3.637 % 11 M $
Newtyn Management LLC
3.376 %
1,771,241 3.376 % 11 M $
Vanguard Fiduciary Trust Co.
3.132 %
1,643,470 3.132 % 10 M $
D.E. Shaw & Co., Inc.
2.304 %
1,208,973 2.304 % 7 M $
ICONIQ Capital LLC
1.938 %
1,016,864 1.938 % 6 M $
SilverArc Capital Management LLC
1.906 %
1,000,000 1.906 % 6 M $
Jacobs Levy Equity Management, Inc.
1.379 %
723,675 1.379 % 4 M $

Company contact information

Kodiak Sciences, Inc.

1200 Page Mill Road

94304, Palo Alto

+650 281 0850

http://www.kodiak.com
address Kodiak Sciences Inc.(KOD)